litlas
Log inCreate account

Falk Nimmerjahn

Active 2003–2025

106
Papers
23,713
Citations
75
h-index
103
i10-index

Citations

Citations per year for Falk Nimmerjahn1983: 1 citations1994: 2 citations1997: 2 citations2002: 1 citations2003: 4 citations2004: 4 citations2005: 28 citations2006: 73 citations2007: 173 citations2008: 207 citations2009: 205 citations2010: 265 citations2011: 257 citations2012: 316 citations2013: 331 citations2014: 343 citations2015: 400 citations2016: 322 citations2017: 359 citations2018: 326 citations2019: 955 citations2020: 935 citations2021: 836 citations2022: 675 citations2023: 523 citations2024: 888 citations2025: 429 citations2026: 4 citations1984–1993: no citations, so these years are not shown1995–1996: no citations, so these years are not shown1998–2001: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,463 citing papers, 26.1% of this breakdownGermany: 862 citing papers, 9.1% of this breakdownChina: 855 citing papers, 9.1% of this breakdownUnited Kingdom: 645 citing papers, 6.8% of this breakdownNetherlands: 443 citing papers, 4.7% of this breakdownFrance: 411 citing papers, 4.3% of this breakdownJapan: 336 citing papers, 3.6% of this breakdownCanada: 272 citing papers, 2.9% of this breakdownAustralia: 263 citing papers, 2.8% of this breakdownSwitzerland: 254 citing papers, 2.7% of this breakdownItaly: 234 citing papers, 2.5% of this breakdownSweden: 202 citing papers, 2.1% of this breakdown
0%26.1%Other 23.3%

Institutions

Fields

  • Medicine52.5%
  • Immunology and Microbiology25.8%
  • Biochemistry, Genetics and Molecular Biology16.3%
  • Neuroscience1.9%
  • Agricultural and Biological Sciences0.7%
  • Nursing0.6%
  • Other2.2%

Topics

  • Monoclonal and Polyclonal Antibodies Research9.1%
  • Glycosylation and Glycoproteins Research5.2%
  • Immune Cell Function and Interaction4.9%
  • T-cell and B-cell Immunology4.7%
  • Immunotherapy and Immune Responses3.4%
  • Immune cells in cancer2.8%
  • Other69.9%

Coauthors

All papers

Open in search
  1. Tissue-specific macrophages: how they develop and choreograph tissue biology

    Authors: Elvira Mass, Falk Nimmerjahn, Katrin Kierdorf, Andreas Schlitzer - Nature reviews. Immunology 2023 cited by 582

  2. Fcγ receptors as regulators of immune responses

    Authors: Falk Nimmerjahn, Jeffrey V. Ravetch - Nature reviews. Immunology 2007 cited by 2,899

  3. Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation

    Authors: Yoshikatsu Kaneko, Falk Nimmerjahn, Jeffrey V. Ravetch - Science 2006 cited by 1,759

  4. Mechanisms of Autoantibody-Induced Pathology

    Authors: Ralf J. Ludwig, Karen Vanhoorelbeke, Frank Leypoldt, Ziya Kaya, Katja Bieber, Sandra M. McLachlan, Lars Komorowski, Jie Luo, Otávio Cabral-Marques, Christoph M. Hammers, Jon Lindstrom, Peter Lamprecht, Andrea Fischer, Gabriela Riemekasten, Claudia Tersteeg, Peter Sondermann, Basil Rapoport, Klaus‐Peter Wandinger, Christian Probst, Asmaa El Beidaq, Enno Schmidt, A. S. Verkman, Rudolf A. Manz, Falk Nimmerjahn - Frontiers in Immunology 2017 cited by 461

  5. Divergent Immunoglobulin G Subclass Activity Through Selective Fc Receptor Binding

    Authors: Falk Nimmerjahn, Jeffrey V. Ravetch - Science 2005 cited by 1,055

  6. Stunning of neutrophils accounts for the anti-inflammatory effects of clodronate liposomes

    Authors: Stephan Culemann, Katharina Knab, Maximilien Euler, Anja Wegner, Hilal Garibagaoglu, Jochen A. Ackermann, Kim Fischer, Deborah Kienhöfer, Georgiana Crainiciuc, Jonas Hahn, Anika Grüneboom, Falk Nimmerjahn, Stefan Uderhardt, Andrés Hidalgo, Georg Schett, Markus Hoffmann, Gerhard Krönke - The Journal of Experimental Medicine 2023 cited by 95

  7. Intravenous immunoglobulin therapy: how does IgG modulate the immune system?

    Authors: Inessa Schwab, Falk Nimmerjahn - Nature reviews. Immunology 2013 cited by 801

  8. Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin

    Authors: Ulrike Harre, Dan Georgess, Holger Bang, Aline Bözec, Roland Axmann, Elena Ossipova, Per‐Johan Jakobsson, Wolfgang Baum, Falk Nimmerjahn, Eszter Szarka, Gabriella Sármay, Grit Krumbholz, Elena Neumann, René E. M. Toes, Hans Ulrich Scherer, Anca I. Catrina, Lars Klareskog, Pierre Jurdic, Georg Schett - Journal of Clinical Investigation 2012 cited by 708

  9. Catchup: a mouse model for imaging-based tracking and modulation of neutrophil granulocytes

    Authors: Anja Hasenberg, Mike Hasenberg, Linda Männ, Franziska Neumann, Lars Borkenstein, Manuel Stecher, Andreas Kraus, Daniel R. Engel, Anika Klingberg, Pegah Seddigh, Zeinab Abdullah, Sabrina Klebow, Swen Engelmann, Annegret Reinhold, Sven Brandau, Michaela Seeling, Ari Waisman, Burkhart Schraven, Joachim R. Göthert, Falk Nimmerjahn, Matthias Gunzer - Nature Methods 2015 cited by 277

  10. Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatment

    Authors: Markus Haake, Beatrice Haack, Tina Schäfer, Patrick N. Harter, Greta Mattavelli, Patrick Eiring, Neha Vashist, Florian Wedekink, Sabrina Genßler, Birgitt Fischer, Julia Dahlhoff, Fatemeh Mokhtari, Anastasia Kuzkina, Marij J.P. Welters, T Benz, Lena Sorger, Vincent Thiemann, Giovanni Almanzar, Martina Selle, Klara Thein, J. A. Spath, Maria Cecilia Gonzalez, Carmen Reitinger, Andrea Ipsen-Escobedo, Kilian Wistuba‐Hamprecht, Kristin Eichler, Katharina Filipski, Pia S. Zeiner, Rudi Beschorner, Renske Goedemans, Falk Hagen Gogolla, Hubert Hackl, Rogier W. Rooswinkel, Alexander Thiem, Paula Romer Roche, Hemant Joshi, Dirk Pühringer, Achim Wöckel, Joachim Diessner, Manfred Rüdiger, Eugen Leo, Phil F. Cheng, Mitchell P. Levesque, Matthias Goebeler, Markus Sauer, Falk Nimmerjahn, Christine Schuberth-Wagner, Stefanie von Felten, Michel Mittelbronn, Matthias Mehling, Andreas Beilhack, Sjoerd H. van der Burg, Angela Riedel, Benjamin Weide, Reinhard Dummer, Jörg Wischhusen - Nature Communications 2023 cited by 91

  11. Effect of posttranslational modifications and subclass on IgG activity: from immunity to immunotherapy

    Authors: Falk Nimmerjahn, Gestur Vidarsson, Mark S. Cragg - Nature Immunology 2023 cited by 87

  12. Immune Monitoring of Trans-endothelial Transport by Kidney-Resident Macrophages

    Authors: Efstathios G. Stamatiades, Marie‐Ève Tremblay, Mathieu Bohm, Lucile Crozet, Kanchan Bisht, Daniela Kao, Carolina Coelho, Xiying Fan, William T. Yewdell, Anne Davidson, Peter S. Heeger, Sandra S. Diebold, Falk Nimmerjahn, Frédéric Geissmann - Cell 2016 cited by 201

  13. Regulation of autoantibody activity by the IL-23–TH17 axis determines the onset of autoimmune disease

    Authors: René Pfeifle, Tobias Rothe, Natacha Ipseiz, Hans Ulrich Scherer, Stephan Culemann, Ulrike Harre, Jochen A. Ackermann, Martina Seefried, Arnd Kleyer, Stefan Uderhardt, Haugg Benjamin, Axel J. Hueber, Patrick Daum, Gordon F. Heidkamp, Changrong Ge, Sybille Böhm, Anja Lux, Wolfgang Schuh, Iryna Magorivska, Kutty Selva Nandakumar, Erik Lönnblom, Christoph Becker, Diana Dudziak, Manfred Wuhrer, Yoann Rombouts, Carolien A. M. Koeleman, René E. M. Toes, Thomas Winkler, Rikard Holmdahl, Martin Herrmann, Stephan Blüml, Falk Nimmerjahn, Georg Schett, Gerhard Krönke - Nature Immunology 2016 cited by 311

  14. Recapitulation of IVIG Anti-Inflammatory Activity with a Recombinant IgG Fc

    Authors: Robert M. Anthony, Falk Nimmerjahn, David J. Ashline, Vernon N. Reinhold, James C. Paulson, Jeffrey V. Ravetch - Science 2008 cited by 846

  15. Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcγRIIB and dectin-1

    Authors: Christian M. Karsten, Manoj K. Pandey, Julia Figge, Regina Kilchenstein, Philip R. Taylor, Marcela Rosas, Jacqueline U. McDonald, Selinda J. Orr, Markus Berger, Dominique Petzold, Véronique Blanchard, André Winkler, Constanze Heß, Delyth M. Reid, Irina Majoul, Richard T. Strait, Nathaniel Harris, Gabriele Köhl, Eva Wex, Ralf J. Ludwig, Detlef Zillikens, Falk Nimmerjahn, Fred D. Finkelman, Gordon D. Brown, Marc Ehlers, Jörg Köhl - Nature Medicine 2012 cited by 466

  16. FcγRIV: A Novel FcR with Distinct IgG Subclass Specificity

    Authors: Falk Nimmerjahn, Pierre Bruhns, Ken Horiuchi, Jeffrey V. Ravetch - Immunity 2005 cited by 654

  17. Impact of Immune Complex Size and Glycosylation on IgG Binding to Human FcγRs

    Authors: Anja Lux, Xiaojie Yu, Chris Scanlan, Falk Nimmerjahn - The Journal of Immunology 2013 cited by 270

  18. Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity

    Authors: Nathaniel Washburn, Inessa Schwab, Daniel Ortiz, Naveen Bhatnagar, Jonathan C. Lansing, Amy Medeiros, Steven Tyler, Divya Mekala, Edward Cochran, Hetal Sarvaiya, Kevin Garofalo, Robin Meccariello, James W. Meador, Laura I. Rutitzky, Birgit C. Schultes, Leona Ling, William Avery, Falk Nimmerjahn, Anthony M. Manning, Ganesh V. Kaundinya, Carlos J. Bosques - National Academy of Sciences, Proceedings of the National Academy of Sciences 2015 cited by 226

  19. Dissecting the mechanism of action of intravenous immunoglobulin in human autoimmune disease: Lessons from therapeutic modalities targeting Fcγ receptors

    Authors: Anthony Shock, David P. Humphreys, Falk Nimmerjahn - Journal of Allergy and Clinical Immunology 2020 cited by 68

  20. Fcγ Receptors: Old Friends and New Family Members

    Authors: Falk Nimmerjahn, Jeffrey V. Ravetch - Immunity 2006 cited by 1,063

  21. Cutting Edge: Mincle Is Essential for Recognition and Adjuvanticity of the Mycobacterial Cord Factor and its Synthetic Analog Trehalose-Dibehenate

    Authors: Hanne Schoenen, Barbara Bodendorfer, Kelly Hitchens, Silvia Manzanero, Kerstin Werninghaus, Falk Nimmerjahn, Else Marie Agger, Steffen Stenger, Peter Andersen, Jürgen Ruland, Gordon D. Brown, Christine A. Wells, Roland Lang - The Journal of Immunology 2010 cited by 490

  22. Intravenous immunoglobulin in neurology—mode of action and clinical efficacy

    Authors: Jan D. Lünemann, Falk Nimmerjahn, Marinos C. Dalakas - Nature Reviews Neurology 2015 cited by 305

  23. Glycosylation of immunoglobulin G determines osteoclast differentiation and bone loss

    Authors: Ulrike Harre, Stefanie Lang, René Pfeifle, Yoann Rombouts, Sabine Frühbeißer, Khaled Amara, Holger Bang, Anja Lux, Carolien A. M. Koeleman, Wolfgang Baum, Katharina Dietel, Franziska Gröhn, Vivianne Malmström, Lars Klareskog, Gerhard Krönke, Roland Kocijan, Falk Nimmerjahn, René E. M. Toes, Martin Herrmann, Hans Ulrich Scherer, Georg Schett - Nature Communications 2015 cited by 260

  24. Differential antibody glycosylation in autoimmunity: sweet biomarker or modulator of disease activity?

    Authors: Michaela Seeling, Christin Brückner, Falk Nimmerjahn - Nature Reviews Rheumatology 2017 cited by 181